OR WAIT null SECS
Croda receives two achievements in relation to EXCiPACT.
, a global supplier of specialty ingredients, reports it has received two achievements in relation to EXCiPACT, the voluntary system that reduces the audit burden in the pharmaceutical industry by providing independent third-party certification of manufacturers, suppliers, and distributors of excipients.
Croda’s first EXCiPACT certification covers ingredients manufactured at Rawcliffe Bridge in the UK. This achievement is part of a global program to gain accreditation at the six Croda sites that supply pharmaceutical excipients. In addition, the company reports that Croda’s Head of Global Quality Assurance, Iain Moore, was singled out for driving EXCiPACT forward in a speech by Frank Milek, Chair of The International Pharmaceutical Excipients Council Europe at their annual seminar in Cannes.